Resources

Links & Literature

One of the goals of SPARK is to teach academic scholars the principles of Drug, Medical Device & Diagnostic Development with focus on topics, which are relevant for translational medicine. This teaching approach covers also disciplines such as Legal, Finance, or Industry directed to entrepreneurial scientists.

>>> Educational/Entrepreneurial Forum

Jan 12, 2021 | Fördermöglichkeiten in Deutschland mit Fokus auf Translation

ENTREPRENEURIAL FORUM

Jan 12, 2021 | 17:00 - 18:00 (CET)

Topic: Fördermöglichkeiten in Deutschland mit Fokus auf Translation (Lecture in German)

Speaker: Volker Erb / Technologietransfer Berlin Partner für Wirtschaft und Technologie GmbH

Link to Announcement

-------------------------------------------------

Recommended Materials

Validation Fund BMBF: "Validierung des technologischen und gesellschaftlichen Innovationspotenzials wissenschaftlicher Forschung - VIP+"

Deadline: throughout the year

Contact:

www.vdivde-it.de/vip-plus-kontakt

 

Validation Fund BMBF: "GO-Bio initial"

Deadline: 15 February every year

Contact:

www.vdivde-it.de/vip-plus-kontakt

 

Validation Fund BMBF: "START MTI - Innovative Start-ups für Mensch-Technik-Interaktion"

Deadline: 15 January and 15 July

 

Project Funding BMBF: "KMU innovativ"

Deadline: 15 April and 15 October every year

 

Project Funding BMBF: "Zentrales Innovationsprogramm Mittelstand - ZIM"

Deadline: announcement on the website

 

Project Funding IBB: "ProFIT - Program zur Förderung von Forschung, Innovationen und Technologien"

Deadline: throughout the year

 

Start-Up Grant BMWi: "EXIST - Gründerstipendium"

Deadline: throughout the year

 

Start-Up Grant BMWi: "EXIST - Forschungstransfer"

Deadline: from 1 January to 31 January and from 1 July to 31 July

 

Start-Up Grant IBB: "ProFIT - Frühphasenfinanzierung"

Deadline: throughout the year

 

Start-Up Grant IBB: "GründungsBONUS"

Deadline: throughout the year

 

>>> Helpful Resources: Guide by Subjects

Public and Private Funding

Life Science projects typically have a need for substantial amounts of capital. There are public-sector support programs, typically targeting early-stage projects also known as the pre-seed stage.

Once the project has been further developed, entrepreneurs typicall take the first steps in forming a startup (if they haven't done that before). This is called the seed stage. Seed funding is the first equity funding stage. It represents the first official money that comes from business angels or venture capital investors in exchange for equity. As the startup progresses, it enters into further VC funding stages working towards a successful exit.

Public Financing Sources - a selection of funding programs targeting early stage projects 

European Commission - Horizon 2020

EXIST - Forschungstransfer (BMWi)

EXIST - Gründerstipendium (BMWi)

Förderung durch Stiftungen

GO-Bio initial (BMBF)

GründungsBONUS (IBB)

KMU innovativ (BMBF)

Nationale Dekade gegen Krebs (BMBF)

ProFIT (ILB)

ProFIT - Frühphasenfinanzierung (IBB)

ProFIT - Program zur Förderung von Forschung, Innovationen und Technologien (IBB)

Research in Germany

START MTI - Innovative Start-ups für Mensch-Technik-Interaktion (BMBF)

Berliner Startup Stipendium

Validierung des technologischen und gesellschaftlichen Innovationspotenzials wissenschaftlicher Forschung - VIP+ (BMBF)

Zentrales Innovationsprogramm Mittelstand - ZIM" (BMBF)
 

Equity Financing Sources - a selection of public and private venture capital firms based in Germany targeting startups in the life science sector

Brandenburg Kapital

DieBrückenKöpfe

Earlybird

High-Tech Gründerfonds

IBB Ventures

NRW.Bank

Peppermint Venture Partners

Speedinvest

TVM Capital

Wellington Partners

SPARK Global

The extraordinary and successful (hi)story of SPARK. From the idea to the product.

In 2006, Professor Daria Mochly-Rosen created and founded the SPARK program at Stanford University in the USA. She serves as President and Founder of the SPARK Global organization.

SPARK is an extraordinary link between the university and industry sectors that aims to provide the training and mentoring necessary to take medical discoveries from research to application. Worldwide, the SPARK model has now been adopted in more than 70 institutes.

Video "Welcome Note and Overview of the Day – Kevin Grimes, SPARK Co-Director"

Video "SPARKee Story – Prof. Craig Garner, SPARK Berlin founder"

Video "TEDMED: SPARKing a New Generation in Translational Research – Prof. Daria Mochly-Rosen

“A Practical Guide to Drug Development in Academia” – written by Daria Mochly-Rosen and Kevin Grimes; 2014, Stanford USA
This book is a helpful companion for people who have already founded or want to establish their own translational research programs. It gives a general overview of the fundamental subjects in the development process.

SPARK-BIH is a member of the SPARK Global network